Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
- | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 105 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 225 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 202 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 145 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 120 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 221 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 61 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 79.7 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | C | 0.0 | BCD100427B001 | 84.3 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | C | 0.5 | BCD100427B003 | 157 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | C | 1.0 | BCD100427B007 | 306 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | C | 2.0 | BCD100427B011 | 150 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | C | 4.0 | BCD100427B015 | 153 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | C | 8.0 | BCD100427B019 | 88.6 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | C | 12.0 | BCD100427B023 | 156 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | C | 24.0 | BCD100427B027 | 42.5 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 150 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 139 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 129 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 122 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 258 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 36.9 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 91.5 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol | 0.5 | BCD100427B004 | 285 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol | 1.0 | BCD100427B008 | 147 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol | 2.0 | BCD100427B012 | 337 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol | 4.0 | BCD100427B016 | 135 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol | 8.0 | BCD100427B020 | 73.3 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol | 12.0 | BCD100427B024 | 246 | pmol/sample |
- | PE(36:4e)/PE(36:3p) | 25OH-Chol | 24.0 | BCD100427B028 | 18.4 | pmol/sample |